Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 500 of 563 entries
View as:

Cognitive Outcomes After Brain Substructure-informed Radiation Planning in Pediatric Patients

Phase: N/A Priority: Normal
NCT ID: NCT05658731 Org: User:
Start: 05/17/23 End: 12/31/35 Due: 12/31/36

SBRT as a Vaccination for Metastatic Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT04042506 Org: User:
Start: 11/26/19 End: 01/26/21 Due: 01/26/22

DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Fibrolamellar Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04248569 Org: User:
Start: 04/20/20 End: 03/01/27 Due: 03/01/28

Melanoma Biomarker Study

Phase: N/A Priority: Normal
NCT ID: NCT00348088 Org: User:
Start: 05/31/06 End: 09/30/11 Due: 09/30/12

Peripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients With Malignant Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00007813 Org: User:
Start: 05/31/97 End: 02/01/05 Due: 02/01/06

Prevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT00003538 Org: User:
Start: 03/31/97 End: 05/31/04 Due: 05/31/05

Behavioral Weight Loss Program for Cancer Survivors in Maryland

Phase: N/A Priority: Normal
NCT ID: NCT04534309 Org: User:
Start: 09/22/20 End: 06/30/23 Due: 06/30/24

Trial of Anti-Tim-3 in Combination With Anti-PD-1 and SRS in Recurrent GBM

Phase: N/A Priority: Normal
NCT ID: NCT03961971 Org: User:
Start: 02/18/20 End: 09/30/25 Due: 09/30/26

Pathologic and Immunologic Response After Ablative Radiation in Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03603002 Org: User:
Start: 10/16/18 End: 03/31/26 Due: 03/31/27

Tumor Tissue Analysis in Patients Receiving Imatinib Mesylate for Malignant Glioma

Phase: N/A Priority: Normal
NCT ID: NCT00401024 Org: User:
Start: 10/12/06 End: 11/11/08 Due: 11/11/09

Protein Biomarker in Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00465842 Org: User:
Start: 06/20/06 End: 08/14/13 Due: 08/14/14

Bariatric Arterial Embolization for Men Starting Hormones for Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04331717 Org: User:
Start: 11/16/20 End: 12/31/23 Due: 12/31/24

Interleukin-2 Following Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00003962 Org: User:
Start: 04/30/98 End: 06/30/00 Due: 06/30/01

Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Metastatic Colorectal Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT01639131 Org: User:
Start: 09/10/12 End: 03/11/19 Due: 03/11/20

The COSMYC Trial (COmbined Suppression of MYC)

Phase: N/A Priority: Normal
NCT ID: NCT06922318 Org: User:
Start: 08/30/25 End: 08/30/31 Due: 08/30/32

Hypofractionated Adaptive Image-Guided Radiation Therapy for Localized Adenocarcinoma of the Prostate

Phase: N/A Priority: Normal
NCT ID: NCT00809991 Org: User:
Start: 12/22/08 End: 09/30/25 Due: 09/30/26

MS-275 in Treating Patients With Hematologic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00015925 Org: User:
Start: 02/28/01 End: - Due: -

Incidence of Intracranial Hemorrhage in Glioma Patients With Venous Thromboembolism Converted From LMWH to Apixaban

Phase: N/A Priority: Normal
NCT ID: NCT04895553 Org: User:
Start: 08/01/21 End: 08/05/22 Due: 08/05/23

Optimized Antiretroviral Therapy During Allogeneic Hematopoietic Stem Cell Transplantation in HIV-1 Individuals

Phase: N/A Priority: Normal
NCT ID: NCT01836068 Org: User:
Start: 06/30/13 End: 06/05/21 Due: 06/05/22

Neoadjuvant Enoblituzumab (MGA271) in Men With Localized Intermediate and High-Risk Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02923180 Org: User:
Start: 02/14/17 End: 07/31/25 Due: 07/31/26

Study of Colon GVAX and Cyclophosphamide in Patients With Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00656123 Org: User:
Start: 03/31/08 End: 01/31/13 Due: 01/31/14

Intra-arterial Chemotherapy for the Treatment of Intraocular Retinoblastoma

Phase: N/A Priority: Normal
NCT ID: NCT01293539 Org: User:
Start: 03/31/11 End: 08/31/16 Due: 08/31/17

Donor Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00003960 Org: User:
Start: 04/30/98 End: 09/30/01 Due: 09/30/02

SMART-ER: Symptom Monitoring With Patient-reported Outcomes

Phase: N/A Priority: Normal
NCT ID: NCT05560685 Org: User:
Start: 10/03/22 End: 11/03/25 Due: 11/03/26

Spect Analysis of Cardiac Perfusion Changes After Whole Breast/Chest Wall Radiation Therapy With ABC

Phase: N/A Priority: Normal
NCT ID: NCT00321048 Org: User:
Start: 06/30/06 End: 01/31/10 Due: 01/31/11